Xeraya Capital
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, Singapore, China, India, France, Italy, Spain, Mexico, Indonesia, South Korea, Vietnam, Malaysia, New Zealand, Philippines, Thailand
Industries Focus
- Technology
- Healthcare
- Consumer Goods
- Telecommunications
- Media
- Renewable Energy
- Agriculture
- Food and Beverage
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Chemicals
- Materials Science
- Environmental Services
Investment Size:
5,000,000 to 50,000,000 USD
Investor Details Founded: 2012
Xeraya Capital is a private equity and venture capital firm specializing in life sciences investments. The firm aims to generate superior investment returns by actively participating in and nurturing its portfolio companies, ensuring that each investment not only delivers financial returns but also brings benefits to humanity, including Malaysia and the surrounding region.
The firm's investment strategy encompasses various stages, including early stage, growth, and late stage, and spans multiple geographical regions, including the United States, Europe, and Asia. Xeraya Capital's portfolio includes companies in sectors such as healthcare, biotechnology, medical devices, pharmaceuticals, diagnostics, agriculture, food and beverage, environmental services, renewable energy, materials science, chemicals, consumer goods, technology, media, and telecommunications.
Xeraya Capital is committed to ethical business practices and strategic partnerships, focusing on investments that develop medical innovations, biotechnological advancements, and sustainable health solutions. The firm holds a restricted capital markets services license issued by the Securities Commission Malaysia, allowing it to conduct equity trading activities and provide investment advice as a licensed broker.
Requirements
- Focus on life sciences sector
- Commitment to ethical business practices
- Strategic partnerships
- Development of medical innovations
- Biotechnological advancements
- Sustainable health solutions
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Liquidia
- Foghorn Therapeutics
- ViewRay
- Iconic Therapeutics
- Congenica
- InterVenn BioSciences
Mentioned In
-
$24.95
-
$14.95
-
$14.95
-
$19.95
-
$9.95
-
$9.95
-
$9.95
-
$19.95
-
$19.95
-
$39.95
-
$95.00
-
$99.00
Claim this Investor
Are you an official representative of Xeraya Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim